Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity

Cell Proliferation

Volumn 46, Issue 2, 2013, Pages 203-213

  Loganathan, R ^a,b   Selvaduray, K R ^a   Nesaretnam, K ^a   Radhakrishnan, A K ^b  

^a MALAYSIAN PALM OIL BOARD   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; DELTA TOCOTRIENOL; ESTROGEN; GAMMA TOCOTRIENOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PALM OIL; TOCOTRIENOL ENRICHED FRACTION; TOCOTRIENOL RICH FRACTION; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL POPULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; COULTER COUNTER; DRUG EFFECT; ELISA KIT; HUMAN; HUMAN CELL; IC 50; PROTEIN CLEAVAGE; TRIPLE NEGATIVE BREAST CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL COUNT; CELL PROLIFERATION; CHROMANS; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MCF-7 CELLS; NF-KAPPA B P50 SUBUNIT; PACLITAXEL; PLANT OILS; POLY(ADP-RIBOSE) POLYMERASES; PROTEOLYSIS; REAGENT KITS, DIAGNOSTIC; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 84875313028     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12014     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153-156.
2. Hisham AN, Yip CH (2004) Overview of breast cancer in Malaysian women: a problem with late diagnosis. Asian J Surg. 27, 130-133.
3. Hisham AN, Yip CH (2003) Spectrum of breast cancer in Malaysian women: overview. World J. Surg. 27, 921-923.
4. Kaufman HL, Wadler S, Antman K (2011) Molecular Targeting in Oncology (Cancer Drug Discovery and Development). Humana Press., Totowa, Nj: 1617376531.
5. Ricci MS, Wei-Xing Z (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11, 342-357.
6. Fulda S, Gorman Am, Hori O, Samali A (2010) Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, Article ID 214074, 1-23; doi:10.1155/2010/214074
7. Tassiulas I, Park-Min K, Hu Y, Kellerman L, Mevorach D, Ivashkiv LB (2007) Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum. Immunol. 68, 156-164.
8. Koh DW, Dawson TM, Dawson VL (2005) Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol. Res. 52, 5-14.
9. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, Dawson VL (2006) Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl Acad. Sci. USA 103, 18314-18319.
10. Chaitanya GV, Babu PP (2009) Differential PARP Cleavage: an indication of heterogeneous forms of cell death and involvement of multiple proteases in the infarct of focal cerebral ischemia in rat. Cell. Mol. Neurobiol. 29, 563-573.
11. Hassa PO, Hottiger MO (2002) The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders. Cell. Mol. Life Sci. 59, 1534-1553.
12. Sodhi RK, Singh N, Jaggi AS (2010) Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascul. Pharmacol. 53, 77-87.
13. Devalaraja-Narashimha K, Padanilam BJ (2010) PARP1 deficiency exacerbates diet-induced obesity in mice. J. Endocrinol. 205, 243-252.
14. Virag L, Szabo E, Bakondi E, Bai P, Gergely P, Hunyadi J, Szabo C (2002) Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin. Exp. Dermatol. 11, 189-202.
15. Domagala P, Huzarski T, Lubinski J, Gugala K, Domagala W (2011) PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy. Breast Cancer Res. Treat. 127, 861-869.
16. Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin AS Jr (2001) The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 Transition Mol. Cell Biol. 21, 8428-8436.
17. Nesaretnam K, Guthrie N, Chambers AF, Carroll KK (1995) Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30, 1139-1142.
18. McIntyre BS, Briski KP, Gapor A, Sylvester PW (2000) Antiproliferative and Apoptotic Effects of Tocopherols and Tocotrienols on Preneoplastic and Neoplastic Mouse Mammary Epithelial Cells. PSEBM 224, 292-301.
19. Srivastava JK, Gupta S (2006) Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem. Biophys. Res. Commun. 346, 447-453.
20. Ahn KS, Sethi G, Krishnan K, Aggarwal BB (2007) γ-Tocotrienol inhibits nuclear factor-κb signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 282, 809-820.
21. Nesaretnam K, Stephen R, Dils R, Darbre P (1998) Tocotrienols inhibits the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33, 461-469.
22. Sylvester PW, Russell M, Ip MM, Ip C (1986) Comparative effects of different animal and vegetable fats before and during carcinogenesis administration on mammary tumorigenesis, sexual maturation and endocrine function in rats. Cancer Res. 46, 757-762.
23. Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Canali R, Virgili F (2004) Tocotrienol-Rich Fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 39, 459-467.
24. Nesaretnam K, Koon TH, Selvaduray KR, Bruno RS, Ho E (2008) Modulation of cell growth and apoptosis response in human prostate cancer cells supplemented with tocotrienols. Eur. J. Lipid Sci. Technol. 110, 23-31.
25. Yu FL, Gapor A, Bender W (2005) Evidence for the preventive effect of the polyunsaturated phytol side chain in tocotrienols on 17β-estradiol epoxidation. Cancer Detect. Prev. 29, 383-388.
26. Aggarwal BB, Sundaram C, Prasad S, Kannappan R (2010) Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol. 80, 1613-1631.
27. Cordell GA, Kinghorn AD, Pezzuto JM (1996) Separation, structure elucidation, and bioassay of cytotoxic natural products. In: Colegate SM, Molyneux RJ, eds. Bioactive natural products: Detection, isolation and structural determination, pp. 196-216. London: CRC Press.
28. Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC (2003) Antileukemic activity of selected natural products in Taiwan. Am. J. Chin. Med. 31, 37-46.
29. Er HM, Cheng EH, Radhakrishnan AK (2007) Anti-proliferative and mutagenic activities of aqueous and methanol extracts of leaves from Pereskia bleo (Kunth) DC (Cactaceae). J. Ethnopharmacol. 113, 448-456.
30. Yam ML, Abdul Hafid SR, Cheng HW, Nesaretnam K (2009) Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids, 44, 787-789.
31. Zenhom M, Hyder A, de Vrese M, Heller KJ, Roeder T, Schrezenmeir J (2011) Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARg and peptidoglycan recognition protein 3. J. Nutr. 141, 971-977.
32. Clarke RB, Laidlaw IJ, Jones LJ, Howell A, Anderson E (1993) Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. Br. J. Cancer 67, 606-611.
33. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, Sylvester PW (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35, 171-180.
34. Sakai M, Okabe M, Yamasaki M, Tachibana H, Yamada K (2004) Induction of apoptosis by tocotrienol in rat hepatoma dRLh-84 cells. Anticancer Res. 24, 1683-1688.
35. Sakai M, Okabe M, Tachibana H, Yamada K (2006) Apoptosis induction by γ-tocotrienol in human hepatoma Hep3B cells. J. Nutr. Biochem. 17, 672-676.
36. Yap WN, Chang PN, Han HY, Lee TW, Ling M, Wong YC, Yap YL (2008) γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br. J. Cancer 99, 1832-1841.
37. McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H (2007) Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med. 232, 523-531.
38. Mo H, Elson CE (1999) Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J. Nutr. 129, 804-813.
39. Birringer M, Lington D, Vertuani S, Manfredini S, Scharlau D, Glei M, Ristow M (2010) Proapoptotic effects of long-chain vitamin E metabolites in HepG2 cells are mediated by oxidative stress. Free Radic. Biol. Med. 49, 1315-1322.
40. Yano Y, Satoh H, Fukumoto K, Kumadaki I, Ichikawa T, Yamada K, Hagiwara K, Yano T (2005) Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha-tocotrienol, a redox silent derivative of alpha-tocotrienol. Int. J. Cancer 115, 839-846.
41. Guthrie N, Gapor A, Chambers AF, Carroll KK (1997) Palm oil tocotrienols and plant flavonoids act synergistically with each other and with Tamoxifen in inhibiting proliferation and growth of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells in culture. Asia Pacific J. Clin. Nutr. 6, 41-45.
42. Viola V, Pilolli F, Piroddi M, Pierpaoli E, Orlando F, Provinciali M, Betti M, Mazzini F, Galli F (2012) Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E. Genes Nutr. 7, 29-41.
43. Pierpaoli E, Viola V, Pilolli F, Piroddi M, Galli F, Provinciali M (2010) γ- and δ-tocotrienols exert a more potent anticancer effect than α-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression. Life Sci. 86, 668-675.
44. Wu D, Ingram A, Lahti JH, Mazza B, Grenet J, Kapoor A, Liu L, Kidd VJ, Tang D (2002) Apoptotic release of histones from nucleosomes. J. Biol. Chem. 277, 12001-12008.
45. Jagtap P, Szabo C (2005) Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 4, 421-440.